| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Selenoproteins | 57 | 2025 | 155 | 8.110 |
Why?
|
| Selenium | 44 | 2025 | 155 | 7.260 |
Why?
|
| Selenocysteine | 38 | 2025 | 58 | 4.860 |
Why?
|
| Lyases | 12 | 2025 | 56 | 4.110 |
Why?
|
| Selenoprotein P | 20 | 2022 | 45 | 3.880 |
Why?
|
| Iodide Peroxidase | 29 | 2025 | 40 | 2.500 |
Why?
|
| Protein Biosynthesis | 23 | 2007 | 132 | 1.990 |
Why?
|
| Proteins | 18 | 2003 | 382 | 1.870 |
Why?
|
| RNA, Messenger | 27 | 2017 | 1271 | 1.750 |
Why?
|
| Schools, Medical | 5 | 2018 | 208 | 1.570 |
Why?
|
| Animals | 94 | 2025 | 16992 | 1.530 |
Why?
|
| Leptin | 5 | 2021 | 118 | 1.530 |
Why?
|
| Energy Metabolism | 8 | 2025 | 187 | 1.510 |
Why?
|
| RNA-Binding Proteins | 14 | 2009 | 161 | 1.450 |
Why?
|
| RNA, Transfer, Amino Acid-Specific | 6 | 2021 | 13 | 1.370 |
Why?
|
| Obesity | 10 | 2025 | 1151 | 1.360 |
Why?
|
| Mercury | 3 | 2024 | 39 | 1.360 |
Why?
|
| Hypothalamus | 4 | 2019 | 120 | 1.230 |
Why?
|
| Codon | 13 | 2006 | 39 | 1.220 |
Why?
|
| Molecular Biology | 3 | 2015 | 47 | 1.180 |
Why?
|
| Brain | 9 | 2017 | 1472 | 1.090 |
Why?
|
| Mice, Knockout | 17 | 2025 | 1035 | 1.060 |
Why?
|
| Sex Characteristics | 3 | 2021 | 258 | 0.990 |
Why?
|
| Oxidative Stress | 17 | 2025 | 1003 | 0.980 |
Why?
|
| Mice | 36 | 2025 | 6644 | 0.970 |
Why?
|
| Cell Line | 27 | 2014 | 1410 | 0.970 |
Why?
|
| Glutathione Peroxidase | 15 | 2025 | 112 | 0.950 |
Why?
|
| Adipocytes, Brown | 2 | 2025 | 15 | 0.900 |
Why?
|
| Neurons | 5 | 2022 | 1263 | 0.890 |
Why?
|
| Seafood | 4 | 2024 | 26 | 0.830 |
Why?
|
| Mice, Inbred C57BL | 15 | 2025 | 1869 | 0.790 |
Why?
|
| Nerve Tissue Proteins | 3 | 2015 | 386 | 0.780 |
Why?
|
| Humans | 78 | 2024 | 43102 | 0.770 |
Why?
|
| Cell Biology | 2 | 2014 | 13 | 0.760 |
Why?
|
| Body Weight | 4 | 2021 | 429 | 0.740 |
Why?
|
| Eukaryotic Cells | 7 | 2008 | 35 | 0.720 |
Why?
|
| Codon, Terminator | 8 | 2013 | 12 | 0.710 |
Why?
|
| Endocrinology | 1 | 2021 | 2 | 0.690 |
Why?
|
| Thermogenesis | 1 | 2021 | 26 | 0.670 |
Why?
|
| Cysteine | 9 | 2024 | 103 | 0.670 |
Why?
|
| RNA, Transfer, Amino Acyl | 9 | 2013 | 9 | 0.640 |
Why?
|
| Peptide Elongation Factors | 7 | 2008 | 11 | 0.620 |
Why?
|
| Agouti-Related Protein | 1 | 2019 | 10 | 0.610 |
Why?
|
| Gene Deletion | 4 | 2021 | 168 | 0.610 |
Why?
|
| Glutathione | 5 | 2007 | 171 | 0.600 |
Why?
|
| 3' Untranslated Regions | 3 | 2008 | 82 | 0.590 |
Why?
|
| Universities | 2 | 2015 | 559 | 0.590 |
Why?
|
| Adipose Tissue, Brown | 5 | 2025 | 46 | 0.560 |
Why?
|
| Fetal Blood | 2 | 2015 | 48 | 0.540 |
Why?
|
| Thyroid Hormones | 5 | 2005 | 35 | 0.540 |
Why?
|
| Molecular Sequence Data | 24 | 2014 | 1542 | 0.540 |
Why?
|
| Amino Acid Sequence | 21 | 2014 | 1180 | 0.500 |
Why?
|
| Transfection | 18 | 2017 | 532 | 0.500 |
Why?
|
| Male | 28 | 2025 | 23409 | 0.480 |
Why?
|
| Research | 2 | 2015 | 181 | 0.470 |
Why?
|
| Liver | 11 | 2021 | 511 | 0.470 |
Why?
|
| DNA-Binding Proteins | 3 | 2009 | 561 | 0.460 |
Why?
|
| Female | 24 | 2025 | 24698 | 0.460 |
Why?
|
| Curriculum | 1 | 2018 | 318 | 0.450 |
Why?
|
| Bambusa | 3 | 2010 | 8 | 0.440 |
Why?
|
| Phosphotransferases | 7 | 2014 | 36 | 0.440 |
Why?
|
| Gene Expression Regulation | 8 | 2017 | 1070 | 0.440 |
Why?
|
| Neurodegenerative Diseases | 2 | 2014 | 141 | 0.430 |
Why?
|
| Education, Graduate | 2 | 2014 | 31 | 0.430 |
Why?
|
| Nucleic Acid Conformation | 7 | 2006 | 154 | 0.430 |
Why?
|
| Up-Regulation | 4 | 2015 | 536 | 0.430 |
Why?
|
| Behavior, Animal | 2 | 2014 | 373 | 0.420 |
Why?
|
| Seizures | 1 | 2014 | 79 | 0.400 |
Why?
|
| Blotting, Western | 9 | 2015 | 883 | 0.400 |
Why?
|
| Hawaii | 8 | 2023 | 2011 | 0.400 |
Why?
|
| Palmitic Acid | 2 | 2015 | 23 | 0.390 |
Why?
|
| Biomedical Research | 4 | 2023 | 502 | 0.390 |
Why?
|
| Base Sequence | 16 | 2007 | 983 | 0.370 |
Why?
|
| Mammals | 4 | 2009 | 112 | 0.370 |
Why?
|
| Genome, Human | 1 | 2013 | 144 | 0.370 |
Why?
|
| Putamen | 1 | 2012 | 16 | 0.360 |
Why?
|
| Substantia Nigra | 1 | 2012 | 52 | 0.350 |
Why?
|
| Transcription, Genetic | 5 | 2009 | 592 | 0.350 |
Why?
|
| Plant Extracts | 3 | 2011 | 302 | 0.350 |
Why?
|
| Antioxidants | 5 | 2013 | 443 | 0.340 |
Why?
|
| Cloning, Molecular | 6 | 2021 | 314 | 0.330 |
Why?
|
| DNA Transposable Elements | 2 | 2002 | 55 | 0.330 |
Why?
|
| Superoxides | 2 | 2007 | 57 | 0.330 |
Why?
|
| Glutathione Transferase | 3 | 2010 | 90 | 0.320 |
Why?
|
| Placenta | 3 | 2024 | 117 | 0.320 |
Why?
|
| Dietary Supplements | 4 | 2016 | 213 | 0.320 |
Why?
|
| Cytosol | 1 | 2010 | 97 | 0.310 |
Why?
|
| Parkinson Disease | 1 | 2012 | 210 | 0.310 |
Why?
|
| Flow Cytometry | 2 | 2008 | 411 | 0.310 |
Why?
|
| Disease | 1 | 2009 | 21 | 0.300 |
Why?
|
| Transcription Factors | 2 | 2015 | 735 | 0.300 |
Why?
|
| Fishes | 2 | 2024 | 73 | 0.300 |
Why?
|
| Cognition | 1 | 2013 | 473 | 0.300 |
Why?
|
| Ribosomes | 2 | 2006 | 35 | 0.300 |
Why?
|
| Methylmercury Compounds | 1 | 2009 | 4 | 0.300 |
Why?
|
| Mercury Poisoning | 1 | 2009 | 5 | 0.300 |
Why?
|
| Ribosomal Proteins | 2 | 2008 | 22 | 0.300 |
Why?
|
| Gene Expression | 11 | 2012 | 701 | 0.300 |
Why?
|
| Immunity | 1 | 2008 | 61 | 0.280 |
Why?
|
| Drosophila Proteins | 2 | 2003 | 188 | 0.280 |
Why?
|
| Methamphetamine | 3 | 2015 | 166 | 0.280 |
Why?
|
| Zebrafish Proteins | 2 | 2006 | 55 | 0.280 |
Why?
|
| Membrane Proteins | 3 | 2017 | 561 | 0.280 |
Why?
|
| Alzheimer Disease | 3 | 2015 | 1001 | 0.280 |
Why?
|
| Pregnancy | 5 | 2024 | 1772 | 0.270 |
Why?
|
| Cell Nucleus | 3 | 2006 | 383 | 0.270 |
Why?
|
| Proteome | 2 | 2007 | 152 | 0.270 |
Why?
|
| Databases, Protein | 1 | 2008 | 54 | 0.270 |
Why?
|
| Mutagenesis, Site-Directed | 7 | 2003 | 186 | 0.270 |
Why?
|
| RNA Stability | 1 | 2007 | 28 | 0.270 |
Why?
|
| Weight Gain | 2 | 2019 | 139 | 0.270 |
Why?
|
| Lymphocyte Subsets | 1 | 2007 | 21 | 0.270 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2007 | 15 | 0.270 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2007 | 12 | 0.270 |
Why?
|
| Metabolic Detoxication, Phase II | 1 | 2007 | 5 | 0.270 |
Why?
|
| Hippocampus | 3 | 2007 | 594 | 0.270 |
Why?
|
| Lung | 2 | 2007 | 492 | 0.270 |
Why?
|
| Apoferritins | 1 | 2007 | 5 | 0.260 |
Why?
|
| Adiposity | 2 | 2019 | 157 | 0.260 |
Why?
|
| Calcium | 1 | 2010 | 491 | 0.260 |
Why?
|
| Neuroprotective Agents | 1 | 2010 | 269 | 0.260 |
Why?
|
| RNA, Transfer | 7 | 2008 | 29 | 0.250 |
Why?
|
| Asthma | 2 | 2008 | 416 | 0.250 |
Why?
|
| Diet | 5 | 2016 | 826 | 0.250 |
Why?
|
| Cerebral Cortex | 1 | 2008 | 306 | 0.250 |
Why?
|
| Rats | 20 | 2013 | 3735 | 0.250 |
Why?
|
| Minority Groups | 3 | 2023 | 690 | 0.250 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 166 | 0.250 |
Why?
|
| Chemoprevention | 1 | 2006 | 41 | 0.250 |
Why?
|
| Pre-Eclampsia | 2 | 2019 | 67 | 0.240 |
Why?
|
| Signal Transduction | 3 | 2021 | 2157 | 0.240 |
Why?
|
| Tetraodontiformes | 1 | 2005 | 4 | 0.240 |
Why?
|
| Fish Proteins | 1 | 2005 | 16 | 0.240 |
Why?
|
| Cells, Cultured | 4 | 2021 | 1621 | 0.240 |
Why?
|
| Multiprotein Complexes | 1 | 2006 | 56 | 0.230 |
Why?
|
| Thioredoxin-Disulfide Reductase | 2 | 2009 | 7 | 0.230 |
Why?
|
| Glucose Intolerance | 2 | 2018 | 40 | 0.230 |
Why?
|
| Buthionine Sulfoximine | 1 | 2005 | 13 | 0.230 |
Why?
|
| Mutation, Missense | 1 | 2005 | 91 | 0.230 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2009 | 652 | 0.220 |
Why?
|
| Blood Glucose | 2 | 2018 | 389 | 0.220 |
Why?
|
| Lipid Metabolism | 1 | 2025 | 148 | 0.210 |
Why?
|
| Oxidation-Reduction | 4 | 2025 | 457 | 0.210 |
Why?
|
| Protein Structure, Tertiary | 4 | 2014 | 423 | 0.210 |
Why?
|
| Age Factors | 2 | 2018 | 1154 | 0.200 |
Why?
|
| Mitochondria | 1 | 2007 | 523 | 0.200 |
Why?
|
| Brain Diseases | 1 | 2003 | 31 | 0.200 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 2000 | 49 | 0.200 |
Why?
|
| Sequence Homology, Amino Acid | 9 | 2006 | 267 | 0.200 |
Why?
|
| Mutation | 7 | 2017 | 1177 | 0.200 |
Why?
|
| Myocytes, Cardiac | 1 | 2025 | 183 | 0.200 |
Why?
|
| Gene Knockdown Techniques | 3 | 2014 | 189 | 0.200 |
Why?
|
| Recombinant Proteins | 6 | 2008 | 518 | 0.190 |
Why?
|
| Sequence Alignment | 5 | 2014 | 272 | 0.190 |
Why?
|
| Genes | 3 | 2019 | 56 | 0.190 |
Why?
|
| Organoselenium Compounds | 2 | 2020 | 9 | 0.190 |
Why?
|
| Amnion | 2 | 2014 | 16 | 0.190 |
Why?
|
| Sequence Analysis, DNA | 2 | 2021 | 515 | 0.180 |
Why?
|
| History, 21st Century | 2 | 2021 | 83 | 0.180 |
Why?
|
| Drosophila melanogaster | 1 | 2003 | 193 | 0.180 |
Why?
|
| History, 20th Century | 2 | 2021 | 121 | 0.180 |
Why?
|
| Peptide Chain Termination, Translational | 1 | 2001 | 1 | 0.180 |
Why?
|
| Peptide Termination Factors | 1 | 2001 | 3 | 0.180 |
Why?
|
| Glucose Tolerance Test | 1 | 2021 | 75 | 0.180 |
Why?
|
| Education, Medical | 2 | 2018 | 118 | 0.180 |
Why?
|
| Disease Models, Animal | 4 | 2021 | 1596 | 0.180 |
Why?
|
| Carbon Dioxide | 1 | 2021 | 86 | 0.170 |
Why?
|
| Polyribosomes | 1 | 2001 | 3 | 0.170 |
Why?
|
| Simvastatin | 1 | 2021 | 29 | 0.170 |
Why?
|
| Amino Acids | 2 | 2019 | 148 | 0.170 |
Why?
|
| Biosynthetic Pathways | 1 | 2021 | 14 | 0.170 |
Why?
|
| RNA Precursors | 2 | 2014 | 28 | 0.170 |
Why?
|
| Protein Binding | 6 | 2007 | 1082 | 0.170 |
Why?
|
| Cell Line, Tumor | 5 | 2017 | 2676 | 0.170 |
Why?
|
| Binding Sites | 5 | 2007 | 671 | 0.160 |
Why?
|
| RNA | 2 | 2005 | 266 | 0.160 |
Why?
|
| Azoles | 1 | 2020 | 12 | 0.160 |
Why?
|
| Genes, Reporter | 3 | 2009 | 148 | 0.160 |
Why?
|
| Promoter Regions, Genetic | 3 | 2014 | 526 | 0.160 |
Why?
|
| Genes, Helminth | 1 | 1999 | 7 | 0.150 |
Why?
|
| Metabolome | 1 | 2019 | 51 | 0.150 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 53 | 0.150 |
Why?
|
| Nutritional Status | 2 | 2020 | 119 | 0.150 |
Why?
|
| Kidney | 6 | 2009 | 372 | 0.150 |
Why?
|
| Caenorhabditis elegans | 1 | 1999 | 80 | 0.140 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 83 | 0.140 |
Why?
|
| Behavioral Research | 1 | 2019 | 41 | 0.140 |
Why?
|
| DNA Primers | 3 | 2009 | 294 | 0.140 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 88 | 0.140 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 316 | 0.140 |
Why?
|
| Selenium Radioisotopes | 4 | 2002 | 4 | 0.140 |
Why?
|
| Minority Health | 1 | 2019 | 95 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2012 | 299 | 0.140 |
Why?
|
| Cell Survival | 3 | 2008 | 945 | 0.140 |
Why?
|
| Orchiectomy | 1 | 2018 | 37 | 0.140 |
Why?
|
| Aged, 80 and over | 4 | 2017 | 2853 | 0.140 |
Why?
|
| Sex Factors | 2 | 2025 | 1028 | 0.140 |
Why?
|
| Histidine | 2 | 2000 | 43 | 0.130 |
Why?
|
| Ovalbumin | 2 | 2007 | 47 | 0.130 |
Why?
|
| Time Factors | 3 | 2018 | 1857 | 0.130 |
Why?
|
| Models, Biological | 5 | 2007 | 712 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 734 | 0.130 |
Why?
|
| Cytoplasm | 3 | 2006 | 154 | 0.130 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2010 | 279 | 0.130 |
Why?
|
| Protein Isoforms | 2 | 2014 | 139 | 0.120 |
Why?
|
| Isoenzymes | 2 | 1997 | 168 | 0.120 |
Why?
|
| Food, Fortified | 1 | 2016 | 11 | 0.120 |
Why?
|
| Phosphoproteins | 2 | 2008 | 206 | 0.120 |
Why?
|
| Epilepsy, Reflex | 1 | 2015 | 3 | 0.120 |
Why?
|
| Castration | 1 | 2015 | 34 | 0.120 |
Why?
|
| Glutamate Decarboxylase | 1 | 2015 | 17 | 0.120 |
Why?
|
| Faculty, Medical | 2 | 2014 | 74 | 0.120 |
Why?
|
| Insulin | 1 | 2018 | 258 | 0.120 |
Why?
|
| Aging | 3 | 2015 | 783 | 0.120 |
Why?
|
| Dizocilpine Maleate | 1 | 2015 | 43 | 0.120 |
Why?
|
| Thyroid Gland | 2 | 1995 | 23 | 0.120 |
Why?
|
| RNA, Transfer, Ser | 2 | 2006 | 3 | 0.120 |
Why?
|
| Child | 1 | 2024 | 3443 | 0.120 |
Why?
|
| tau Proteins | 1 | 2017 | 186 | 0.120 |
Why?
|
| Exploratory Behavior | 1 | 2015 | 78 | 0.120 |
Why?
|
| Maze Learning | 1 | 2015 | 113 | 0.110 |
Why?
|
| Calcium Channels, L-Type | 1 | 2015 | 20 | 0.110 |
Why?
|
| Heat-Shock Proteins | 1 | 2015 | 57 | 0.110 |
Why?
|
| Autoantigens | 2 | 2006 | 87 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2016 | 760 | 0.110 |
Why?
|
| Iodine | 2 | 1997 | 11 | 0.110 |
Why?
|
| Neoplasms | 1 | 2006 | 1377 | 0.110 |
Why?
|
| Genotype | 1 | 2018 | 800 | 0.110 |
Why?
|
| Calcium Channel Blockers | 1 | 2015 | 55 | 0.110 |
Why?
|
| Choroid Plexus | 1 | 2015 | 6 | 0.110 |
Why?
|
| Phenotype | 1 | 2018 | 780 | 0.110 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 1995 | 18 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 863 | 0.110 |
Why?
|
| Anticodon | 1 | 1994 | 1 | 0.110 |
Why?
|
| DNA | 6 | 2014 | 592 | 0.110 |
Why?
|
| Analysis of Variance | 2 | 2017 | 575 | 0.110 |
Why?
|
| Substrate Specificity | 2 | 2014 | 219 | 0.110 |
Why?
|
| Organogenesis | 1 | 2014 | 16 | 0.110 |
Why?
|
| Chorion | 1 | 2014 | 9 | 0.110 |
Why?
|
| RNA Helicases | 1 | 2014 | 19 | 0.110 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2014 | 31 | 0.110 |
Why?
|
| Archaea | 2 | 2007 | 17 | 0.110 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2015 | 69 | 0.110 |
Why?
|
| Myocardium | 2 | 2025 | 263 | 0.100 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2008 | 226 | 0.100 |
Why?
|
| Phosphorylation | 4 | 2017 | 986 | 0.100 |
Why?
|
| HIV Infections | 3 | 2015 | 2586 | 0.100 |
Why?
|
| Point Mutation | 3 | 2003 | 98 | 0.100 |
Why?
|
| Nervous System Diseases | 1 | 2014 | 77 | 0.100 |
Why?
|
| DNA Mutational Analysis | 4 | 2003 | 95 | 0.100 |
Why?
|
| Mice, Inbred Strains | 1 | 1993 | 114 | 0.100 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2014 | 95 | 0.100 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 665 | 0.100 |
Why?
|
| Income | 1 | 2014 | 160 | 0.100 |
Why?
|
| Endocytosis | 1 | 2014 | 118 | 0.100 |
Why?
|
| Trans-Activators | 1 | 2014 | 192 | 0.100 |
Why?
|
| Motor Activity | 1 | 2015 | 437 | 0.100 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2012 | 7 | 0.100 |
Why?
|
| Hyperinsulinism | 1 | 2012 | 17 | 0.100 |
Why?
|
| Ligands | 1 | 2014 | 388 | 0.090 |
Why?
|
| Locomotion | 1 | 2013 | 105 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 749 | 0.090 |
Why?
|
| Adult | 4 | 2024 | 13872 | 0.090 |
Why?
|
| Inflammation | 2 | 2008 | 758 | 0.090 |
Why?
|
| Zebrafish | 2 | 2006 | 146 | 0.090 |
Why?
|
| Bacterial Proteins | 2 | 2007 | 595 | 0.090 |
Why?
|
| RNA, Untranslated | 1 | 2012 | 50 | 0.090 |
Why?
|
| Hypercholesterolemia | 1 | 2012 | 42 | 0.090 |
Why?
|
| Alternative Splicing | 1 | 2012 | 94 | 0.090 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2012 | 68 | 0.090 |
Why?
|
| Stereotaxic Techniques | 1 | 2012 | 20 | 0.090 |
Why?
|
| Precipitin Tests | 2 | 2003 | 52 | 0.090 |
Why?
|
| Fatty Liver | 1 | 2012 | 77 | 0.090 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2012 | 92 | 0.090 |
Why?
|
| alpha-Synuclein | 1 | 2012 | 61 | 0.090 |
Why?
|
| Poaceae | 1 | 2011 | 14 | 0.090 |
Why?
|
| Sequence Analysis, RNA | 2 | 2012 | 115 | 0.090 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 291 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2014 | 310 | 0.090 |
Why?
|
| Open Reading Frames | 2 | 2001 | 79 | 0.080 |
Why?
|
| Dogs | 5 | 1999 | 204 | 0.080 |
Why?
|
| Microscopy, Confocal | 2 | 2008 | 224 | 0.080 |
Why?
|
| RNA Interference | 3 | 2012 | 247 | 0.080 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2010 | 19 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2014 | 403 | 0.080 |
Why?
|
| Feeding Behavior | 1 | 2014 | 469 | 0.080 |
Why?
|
| Oxidants | 1 | 2010 | 42 | 0.080 |
Why?
|
| Chemokine CCL2 | 1 | 2011 | 95 | 0.080 |
Why?
|
| Gene Silencing | 2 | 2008 | 154 | 0.080 |
Why?
|
| Glycosylation | 2 | 2000 | 113 | 0.080 |
Why?
|
| Kinetics | 5 | 1997 | 695 | 0.080 |
Why?
|
| Sulfhydryl Compounds | 1 | 2010 | 51 | 0.080 |
Why?
|
| Luminescent Proteins | 1 | 2010 | 68 | 0.080 |
Why?
|
| Macaca | 1 | 2009 | 36 | 0.080 |
Why?
|
| Reactive Oxygen Species | 2 | 2010 | 532 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 1 | 2010 | 81 | 0.080 |
Why?
|
| Luciferases | 1 | 2009 | 71 | 0.080 |
Why?
|
| RNA, Small Interfering | 4 | 2017 | 436 | 0.080 |
Why?
|
| Triiodothyronine | 3 | 1995 | 36 | 0.080 |
Why?
|
| Homeostasis | 2 | 2022 | 192 | 0.070 |
Why?
|
| Hydrogen Peroxide | 1 | 2010 | 190 | 0.070 |
Why?
|
| Lymphocyte Activation | 1 | 2010 | 249 | 0.070 |
Why?
|
| Telomerase | 1 | 2009 | 42 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2007 | 296 | 0.070 |
Why?
|
| Neocortex | 1 | 2008 | 27 | 0.070 |
Why?
|
| Metals, Heavy | 1 | 2009 | 71 | 0.070 |
Why?
|
| Telomere | 1 | 2009 | 59 | 0.070 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2008 | 29 | 0.070 |
Why?
|
| Cross-Linking Reagents | 1 | 2008 | 51 | 0.070 |
Why?
|
| Aged | 3 | 2017 | 8214 | 0.070 |
Why?
|
| Genomics | 2 | 2008 | 293 | 0.070 |
Why?
|
| Cell Count | 1 | 2008 | 145 | 0.070 |
Why?
|
| Neurofibrillary Tangles | 1 | 2008 | 115 | 0.070 |
Why?
|
| Protein Conformation | 2 | 2003 | 416 | 0.070 |
Why?
|
| Research Personnel | 2 | 2021 | 206 | 0.070 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2008 | 41 | 0.070 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2008 | 69 | 0.070 |
Why?
|
| Phytotherapy | 1 | 2008 | 75 | 0.070 |
Why?
|
| Tissue Distribution | 2 | 2007 | 240 | 0.070 |
Why?
|
| Prokaryotic Cells | 2 | 1999 | 9 | 0.070 |
Why?
|
| Astrocytes | 1 | 2010 | 244 | 0.070 |
Why?
|
| Vero Cells | 1 | 2008 | 112 | 0.070 |
Why?
|
| Sequence Analysis, Protein | 1 | 2008 | 52 | 0.070 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2007 | 18 | 0.070 |
Why?
|
| STAT6 Transcription Factor | 1 | 2007 | 17 | 0.070 |
Why?
|
| Malonates | 1 | 2007 | 2 | 0.070 |
Why?
|
| Polyenes | 1 | 2007 | 4 | 0.070 |
Why?
|
| Antimycin A | 1 | 2007 | 5 | 0.070 |
Why?
|
| Electron Transport Complex II | 1 | 2007 | 6 | 0.070 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2007 | 55 | 0.070 |
Why?
|
| User-Computer Interface | 1 | 2008 | 74 | 0.070 |
Why?
|
| Diabetic Nephropathies | 1 | 2008 | 78 | 0.070 |
Why?
|
| Electron Transport Complex III | 1 | 2007 | 13 | 0.070 |
Why?
|
| Rotenone | 1 | 2007 | 17 | 0.070 |
Why?
|
| High Mobility Group Proteins | 1 | 2007 | 5 | 0.070 |
Why?
|
| Th2 Cells | 1 | 2007 | 62 | 0.070 |
Why?
|
| Depression | 1 | 2015 | 863 | 0.070 |
Why?
|
| Plasmids | 2 | 2003 | 244 | 0.070 |
Why?
|
| Immunoglobulin E | 1 | 2007 | 61 | 0.070 |
Why?
|
| Homocysteine | 1 | 2007 | 21 | 0.070 |
Why?
|
| Electron Transport Complex I | 1 | 2007 | 29 | 0.070 |
Why?
|
| HIV-1 | 1 | 2013 | 755 | 0.060 |
Why?
|
| Allergens | 1 | 2007 | 65 | 0.060 |
Why?
|
| Rats, Inbred Strains | 3 | 1991 | 126 | 0.060 |
Why?
|
| DNA Damage | 1 | 2009 | 356 | 0.060 |
Why?
|
| Mice, Obese | 2 | 2021 | 42 | 0.060 |
Why?
|
| Conserved Sequence | 3 | 1997 | 122 | 0.060 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2008 | 131 | 0.060 |
Why?
|
| Leishmania | 1 | 2006 | 20 | 0.060 |
Why?
|
| Ultraviolet Rays | 1 | 2007 | 118 | 0.060 |
Why?
|
| Sequence Deletion | 1 | 2006 | 93 | 0.060 |
Why?
|
| Nuclear Export Signals | 1 | 2006 | 2 | 0.060 |
Why?
|
| Genetic Code | 1 | 2006 | 7 | 0.060 |
Why?
|
| Environmental Pollutants | 1 | 2009 | 201 | 0.060 |
Why?
|
| Nuclear Localization Signals | 1 | 2006 | 15 | 0.060 |
Why?
|
| Internet | 1 | 2008 | 236 | 0.060 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2006 | 60 | 0.060 |
Why?
|
| Trace Elements | 2 | 2016 | 35 | 0.060 |
Why?
|
| Protein Sorting Signals | 1 | 2005 | 25 | 0.060 |
Why?
|
| Testis | 1 | 2007 | 207 | 0.060 |
Why?
|
| Macromolecular Substances | 1 | 2005 | 92 | 0.060 |
Why?
|
| Homozygote | 1 | 2005 | 77 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 1 | 2007 | 694 | 0.060 |
Why?
|
| Antigens | 1 | 2005 | 59 | 0.060 |
Why?
|
| Heterozygote | 1 | 2005 | 110 | 0.060 |
Why?
|
| Models, Genetic | 1 | 2005 | 183 | 0.060 |
Why?
|
| Academic Medical Centers | 1 | 2005 | 76 | 0.060 |
Why?
|
| Multigene Family | 1 | 2005 | 105 | 0.060 |
Why?
|
| Protozoan Proteins | 1 | 2006 | 191 | 0.060 |
Why?
|
| Evolution, Molecular | 1 | 2006 | 307 | 0.050 |
Why?
|
| Lipid Peroxidation | 1 | 2005 | 140 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2005 | 89 | 0.050 |
Why?
|
| Skin | 1 | 2005 | 187 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2005 | 281 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 1 | 2003 | 32 | 0.050 |
Why?
|
| Neuroblastoma | 2 | 2017 | 136 | 0.050 |
Why?
|
| Cytoprotection | 1 | 2003 | 36 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2019 | 1285 | 0.050 |
Why?
|
| Selenoprotein W | 1 | 2003 | 1 | 0.050 |
Why?
|
| Embryo, Nonmammalian | 1 | 2003 | 59 | 0.050 |
Why?
|
| Cytokines | 1 | 2007 | 678 | 0.050 |
Why?
|
| Research Support as Topic | 2 | 2019 | 89 | 0.050 |
Why?
|
| Methionine | 1 | 2003 | 27 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 704 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2006 | 863 | 0.050 |
Why?
|
| Organ Specificity | 2 | 2000 | 141 | 0.050 |
Why?
|
| Hormones | 1 | 2022 | 55 | 0.050 |
Why?
|
| In Situ Hybridization | 2 | 2000 | 138 | 0.050 |
Why?
|
| Computational Biology | 3 | 2014 | 327 | 0.050 |
Why?
|
| DNA, Complementary | 4 | 1995 | 196 | 0.050 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2002 | 57 | 0.050 |
Why?
|
| Macaca mulatta | 1 | 2002 | 139 | 0.050 |
Why?
|
| Program Development | 1 | 2023 | 240 | 0.050 |
Why?
|
| Consensus Sequence | 2 | 1999 | 21 | 0.050 |
Why?
|
| Databases, Nucleic Acid | 1 | 2002 | 30 | 0.050 |
Why?
|
| Mentors | 1 | 2023 | 145 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 1124 | 0.040 |
Why?
|
| Phylogeny | 1 | 2005 | 769 | 0.040 |
Why?
|
| Blood-Brain Barrier | 1 | 2003 | 173 | 0.040 |
Why?
|
| Methanococcus | 1 | 2001 | 1 | 0.040 |
Why?
|
| Creatinine | 1 | 2021 | 102 | 0.040 |
Why?
|
| Physical Chromosome Mapping | 1 | 2000 | 12 | 0.040 |
Why?
|
| beta-Galactosidase | 1 | 2000 | 37 | 0.040 |
Why?
|
| Adenosine Triphosphate | 2 | 2007 | 206 | 0.040 |
Why?
|
| Maryland | 1 | 2021 | 66 | 0.040 |
Why?
|
| Selenious Acid | 1 | 2020 | 4 | 0.040 |
Why?
|
| Isoindoles | 1 | 2020 | 16 | 0.040 |
Why?
|
| Apoptosis | 1 | 2008 | 1568 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2023 | 760 | 0.040 |
Why?
|
| Sulfotransferases | 2 | 2010 | 9 | 0.040 |
Why?
|
| Chromatography, Affinity | 1 | 2000 | 68 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 508 | 0.040 |
Why?
|
| Virulence | 1 | 2020 | 246 | 0.040 |
Why?
|
| Antibodies | 1 | 2000 | 144 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2006 | 88 | 0.040 |
Why?
|
| Oligonucleotides | 1 | 1999 | 49 | 0.040 |
Why?
|
| Metabolomics | 1 | 2019 | 95 | 0.040 |
Why?
|
| Rabbits | 1 | 1999 | 278 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2019 | 116 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2019 | 134 | 0.040 |
Why?
|
| Virus Replication | 1 | 2020 | 318 | 0.030 |
Why?
|
| Risk Factors | 1 | 2006 | 3994 | 0.030 |
Why?
|
| Cattle | 1 | 1999 | 498 | 0.030 |
Why?
|
| Cell Death | 2 | 2010 | 278 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 1995 | 30 | 0.030 |
Why?
|
| MicroRNAs | 2 | 2014 | 518 | 0.030 |
Why?
|
| Cultural Diversity | 1 | 2019 | 193 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 1997 | 182 | 0.030 |
Why?
|
| Leucine | 1 | 2017 | 31 | 0.030 |
Why?
|
| Structure-Activity Relationship | 3 | 1997 | 506 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2006 | 1092 | 0.030 |
Why?
|
| Proline | 1 | 2017 | 40 | 0.030 |
Why?
|
| Chromosome Mapping | 2 | 1995 | 199 | 0.030 |
Why?
|
| Catalysis | 2 | 1997 | 187 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 2016 | 42 | 0.030 |
Why?
|
| Guanosine Triphosphate | 1 | 1995 | 18 | 0.030 |
Why?
|
| Models, Molecular | 1 | 1999 | 876 | 0.030 |
Why?
|
| Metabolic Diseases | 1 | 2016 | 40 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 934 | 0.030 |
Why?
|
| Glucose | 1 | 2017 | 244 | 0.030 |
Why?
|
| Thyroxine | 1 | 1995 | 22 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2006 | 1723 | 0.030 |
Why?
|
| Tilapia | 1 | 2014 | 11 | 0.030 |
Why?
|
| Blotting, Northern | 3 | 2005 | 150 | 0.030 |
Why?
|
| Philippines | 1 | 2014 | 81 | 0.030 |
Why?
|
| Pacific Islands | 1 | 2014 | 123 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2015 | 282 | 0.030 |
Why?
|
| Mutagenesis | 1 | 1993 | 91 | 0.030 |
Why?
|
| Japan | 1 | 2014 | 348 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2013 | 36 | 0.020 |
Why?
|
| Rats, Transgenic | 1 | 2013 | 34 | 0.020 |
Why?
|
| Dementia | 1 | 2015 | 160 | 0.020 |
Why?
|
| Microsomes, Liver | 1 | 1993 | 75 | 0.020 |
Why?
|
| Young Adult | 2 | 2014 | 5080 | 0.020 |
Why?
|
| Kidney Tubules, Proximal | 1 | 1993 | 34 | 0.020 |
Why?
|
| Untranslated Regions | 1 | 2012 | 6 | 0.020 |
Why?
|
| Ion Transport | 1 | 2012 | 23 | 0.020 |
Why?
|
| Diethyl Pyrocarbonate | 1 | 1992 | 1 | 0.020 |
Why?
|
| Rose Bengal | 1 | 1992 | 3 | 0.020 |
Why?
|
| RNA Splice Sites | 1 | 2012 | 10 | 0.020 |
Why?
|
| Half-Life | 1 | 1992 | 63 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 1992 | 95 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1995 | 460 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2013 | 258 | 0.020 |
Why?
|
| Congenital Hypothyroidism | 1 | 1992 | 4 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2014 | 456 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2019 | 719 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 423 | 0.020 |
Why?
|
| Chromosome Inversion | 1 | 1991 | 9 | 0.020 |
Why?
|
| Reticulocytes | 1 | 1991 | 9 | 0.020 |
Why?
|
| Aurothioglucose | 1 | 1991 | 1 | 0.020 |
Why?
|
| Xenopus | 1 | 1991 | 48 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 1991 | 109 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1991 | 53 | 0.020 |
Why?
|
| Pituitary Gland | 1 | 1991 | 60 | 0.020 |
Why?
|
| Peptides | 1 | 1994 | 372 | 0.020 |
Why?
|
| Intra-Abdominal Fat | 1 | 2011 | 46 | 0.020 |
Why?
|
| Organ Size | 1 | 2011 | 170 | 0.020 |
Why?
|
| Biotransformation | 1 | 2010 | 69 | 0.020 |
Why?
|
| Glucuronosyltransferase | 1 | 2010 | 29 | 0.020 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2010 | 32 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 1990 | 73 | 0.020 |
Why?
|
| Random Allocation | 1 | 2010 | 147 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2010 | 98 | 0.020 |
Why?
|
| Plant Leaves | 1 | 2010 | 136 | 0.020 |
Why?
|
| Energy Intake | 1 | 2010 | 164 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2010 | 138 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2010 | 91 | 0.020 |
Why?
|
| Oocytes | 1 | 1990 | 149 | 0.020 |
Why?
|
| Podocytes | 1 | 2008 | 37 | 0.020 |
Why?
|
| United States | 1 | 2019 | 5205 | 0.020 |
Why?
|
| Flavonoids | 1 | 2008 | 100 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2009 | 346 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2008 | 61 | 0.020 |
Why?
|
| Kidney Glomerulus | 1 | 2008 | 86 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2014 | 2544 | 0.020 |
Why?
|
| Radiation Tolerance | 1 | 2007 | 12 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2009 | 321 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2007 | 44 | 0.020 |
Why?
|
| Archaeal Proteins | 1 | 2007 | 9 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2007 | 21 | 0.020 |
Why?
|
| Transferases | 1 | 2007 | 14 | 0.020 |
Why?
|
| Dipeptides | 1 | 2007 | 31 | 0.020 |
Why?
|
| RNA, Protozoan | 1 | 2006 | 13 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2007 | 97 | 0.020 |
Why?
|
| DNA, Protozoan | 1 | 2006 | 26 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2010 | 638 | 0.020 |
Why?
|
| Chromatography | 1 | 2005 | 17 | 0.010 |
Why?
|
| Total Quality Management | 1 | 2005 | 11 | 0.010 |
Why?
|
| NIH 3T3 Cells | 1 | 2005 | 64 | 0.010 |
Why?
|
| CHO Cells | 1 | 2005 | 123 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2007 | 301 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 127 | 0.010 |
Why?
|
| Serine | 1 | 2005 | 79 | 0.010 |
Why?
|
| Cricetinae | 1 | 2005 | 241 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2005 | 173 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 209 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 256 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2010 | 1455 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2008 | 1766 | 0.010 |
Why?
|
| Gene Products, tat | 1 | 2002 | 36 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2002 | 87 | 0.010 |
Why?
|
| Adolescent | 1 | 2014 | 6081 | 0.010 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2002 | 55 | 0.010 |
Why?
|
| Simian immunodeficiency virus | 1 | 2002 | 60 | 0.010 |
Why?
|
| HIV | 1 | 2002 | 100 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2005 | 1234 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2002 | 201 | 0.010 |
Why?
|
| Disease Progression | 1 | 2002 | 667 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 1019 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 12222 | 0.010 |
Why?
|
| Propylthiouracil | 1 | 1997 | 3 | 0.010 |
Why?
|
| Dithiothreitol | 1 | 1997 | 18 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1997 | 52 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1995 | 42 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1995 | 36 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1995 | 80 | 0.010 |
Why?
|
| Cell-Free System | 1 | 1995 | 15 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 1995 | 83 | 0.010 |
Why?
|
| Introns | 1 | 1995 | 79 | 0.010 |
Why?
|
| Microsomes | 1 | 1995 | 55 | 0.010 |
Why?
|
| Pancreas | 1 | 1995 | 45 | 0.010 |
Why?
|
| Exons | 1 | 1995 | 92 | 0.010 |
Why?
|
| Kidney Cortex | 1 | 1993 | 8 | 0.010 |
Why?
|
| Kidney Medulla | 1 | 1993 | 6 | 0.010 |
Why?
|
| RNA Probes | 1 | 1993 | 11 | 0.010 |
Why?
|
| Genomic Library | 1 | 1992 | 7 | 0.010 |
Why?
|
| Affinity Labels | 1 | 1992 | 7 | 0.010 |
Why?
|